eXoZymes Inc - EXOZ Sales Growth YoY (Last 12 Months)

Invizyne's partnerships with the agricultural and pharmacological sectors are driving biochemical progress, as evidenced by the LTM sales growth YoY. The 0.00 level reflects the state of the parameter amid the scaling of B2B supplies to the cosmetics industry. Final growth is driven by licensing royalties and the successful implementation of cell-free synthesis of complex compounds, strengthening the commercial potential of eXoZymes Inc (EXOZ).
Summary analytical data breakdowns for Invizyne Technologies (EXOZ)

This indicator measures the percentage change in aggregate revenue over the last twelve months relative to the same period last year, smoothing out seasonality and short-term market fluctuations. By analyzing the TTM revenue growth trajectory compared to the previous year, an investor can assess the commercial progress of the biotech startup eXoZymes Inc. (EXOZ), whose current operations are focused on laboratory research in green chemistry and strict compliance with environmental regulations.